UPDATE: Piper Jaffray Cuts PT to $27 on Impax Laboratories on Rytary Launch Visibility
February 26, 2013 at 10:38 AM EST
Piper Jaffray maintained Impax Laboratories (NASDAQ: IPXL ) with an Overweight rating and lowered the price target from $29.00 to $27.00. Piper Jaffray commented, "With a compelling net cash position of now close to $460M... in the context of a $1.3B market cap and 2013 operating cash flows pushing the
